Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.Considering buying GEV stock? Here’s what analysts think: Read This Next: Photo via Shutterstock ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.Considering buying KBH stock? Here’s what analysts think:Read This Next:Photo via Shutterstock ...

Core Insights - Hamilton Insurance Group, Ltd. (NYSE:HG) is a significant entity in the insurance sector with a market capitalization of approximately $2.87 billion [1] Analyst Ratings and Price Targets - Michael Zaremski from BMO Capital has set a price target of $26 for HG, indicating a potential decline of about 8.58% from the current trading price of $28.44 [2] - HG has an average rating of "Moderate Buy" from ten ratings firms, with two analysts recommending holding, seven suggesting buying, and one giving a strong buy recommendation [3] - Wall Street Zen has downgraded HG from a "buy" to a "hold" rating, while Morgan Stanley has set a target price of $28.00, closely aligning with the current trading price of $28.43 [4] - Barclays has increased its price target for HG from $25.00 to $29.00, reflecting a more optimistic outlook [4][6] Stock Performance - HG's stock price has shown slight movement today, with a low of $28.30 and a high of $28.53, and has fluctuated between a high of $28.70 and a low of $16.80 over the past year [5] - The trading volume for HG stands at 33,091 shares, indicating investor interest in the company's performance and future prospects [5]

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.Considering buying AVAV stock? Here’s what analysts think:Read This Next:Photo via Shutterstock ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.Considering buying CRM stock? Here’s what analysts think: Read This Next: Photo via Shutterstock ...

Core Viewpoint - Top Wall Street analysts have revised their outlook on several prominent companies, indicating potential shifts in investment sentiment and opportunities in the market [1] Company Analysis - Analysts are considering UAL stock as a potential buy, reflecting a positive sentiment towards the company's future performance [1]

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.Considering buying SYF stock? Here’s what analysts think: Read This Next:Photo via ShutterstockLoading...Loading... ...

Core Viewpoint - Top Wall Street analysts have revised their outlook on several key stocks, indicating potential investment opportunities and shifts in market sentiment [1] Group 1: Analyst Ratings Changes - Analysts have made notable upgrades and downgrades on various stocks, reflecting changing perspectives on their future performance [1] - The article suggests that investors should consider the insights provided by analysts when evaluating stocks like AMAT [1]

Company Overview - Surgery Partners, Inc. (NASDAQ:SGRY) operates surgical facilities across the United States, providing outpatient surgery, diagnostic imaging, and laboratory services, focusing on cost-effective surgical solutions [1] Price Targets and Analyst Ratings - Mizuho Securities set a price target of $22 for SGRY, indicating a potential upside of 44.74% from its current trading price of $15.20 [2] - Cantor Fitzgerald maintains an "overweight" rating with a price target of $36, while the Royal Bank of Canada has set a $31 target with an "outperform" rating [3] - Benchmark adjusted its price target for SGRY from $35 to $30, maintaining a "buy" rating, whereas Weiss Ratings reaffirmed a "sell (d-)" rating [4] Stock Performance and Trading Activity - SGRY's stock price has decreased to $15.06, a drop of 1.47% or $0.22, with fluctuations between $15.01 and $15.57 [2] - The stock has experienced a 52-week high of $26.16 and a low of $15.01, indicating its volatile nature [5] - There has been a significant surge in options trading activity, with a 498% increase in put options, suggesting investor uncertainty or hedging strategies [3][6] Market Capitalization and Trading Volume - The stock's market capitalization is approximately $1.95 billion, with a trading volume of 1,356,144 shares on the NASDAQ exchange [4]

Core Viewpoint - Top Wall Street analysts have revised their outlook on several prominent companies, indicating potential shifts in investment sentiment and opportunities in the market [1] Group 1: Analyst Ratings Changes - The article highlights that there have been changes in analyst ratings, including upgrades, downgrades, and initiations for various companies [1] - Specific mention is made of Microsoft (MSFT) stock, suggesting that analysts have provided insights on its investment potential [1]